Immunogen | IMGN - Aktiva



Aktiva Perubahan Tanggal
AbbVie USD 133.96B 62M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Amgen USD 90.59B 445M 2025-12
Astellas Pharma JPY 3.6T 153.62B 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Exelixis USD 2.84B 20.87M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
MacroGenics USD 256.85M 13.92M 2025-12
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 25.48B 2025-12